Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Rapport Therapeutics COO Gault sells $281k in stock
Rapport Therapeutics COO Cheryl Gault sold 10,000 shares of common stock for a total of $281,857 on March 30, 2026, under a pre-arranged trading plan. This sale occurred after a significant 176% surge in the company’s stock over the past year. The company recently announced positive fiscal year 2025 earnings and advanced timelines for Phase 3 studies of RAP-219, leading several analysts to reiterate their Buy ratings with increased price targets.